e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Pleural infection and complicated pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Serum Procalcitonin for diagnosing and monitoring response in pleural infection
S. Mohammed (Kettering, United Kingdom), Y. Vali (Kettering, United Kingdom), M. Naeem (Kettering, United Kingdom), R. Reddy (Kettering, United Kingdom)
Source:
International Congress 2019 – Pleural infection and complicated pneumonia
Session:
Pleural infection and complicated pneumonia
Session type:
Poster Discussion
Number:
3840
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Mohammed (Kettering, United Kingdom), Y. Vali (Kettering, United Kingdom), M. Naeem (Kettering, United Kingdom), R. Reddy (Kettering, United Kingdom). Serum Procalcitonin for diagnosing and monitoring response in pleural infection. 3840
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
The role of Procalcitonin in management of pleural infections
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019
Role of markers C-Reactive Protein, Procalcitonin and TREM-1 in diagnosis of infection pleural effusion
Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Year: 2018
Usefulness of serum procalcitonin levels in pulmonary tuberculosis
Source: Eur Respir J 2011; 37: 371
Year: 2011
Pleural fluid procalcitonin levels in identifying pleural effusions due to infection
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009
Value of serum procalcitonin levels in the differential diagnosis of pneumonia and pulmonary embolism
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011
Procalcitonin and CRP levels in pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Usefulness of procalcitonin as a diagnostic marker of pleural effusion
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012
Serum procalcitonin concentrations in children with pulmonary tuberculosis, tuberculous infection and lober pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 176s
Year: 2003
Serum procalcitonin as a potential biomarker of surgery in parapneumonic pleural effusions
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
The diagnostic value of serum procalcitonin in differential diagnosis of pulmonary embolism and pneumonia
Source: Eur Respir J 2007; 30: Suppl. 51, 462s
Year: 2007
Serum lipids as biomarkers for therapeutic monitoring of latent tuberculosis infection
Source: Eur Respir J 2013; 42: 547-550
Year: 2013
High serum procalcitonin and C-reactive protein levels can exclude tuberculosis in community-acquired pneumonia patients with atypical presentation
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
Role of serum and pleural fluid NT-proBNP levels in identifying pleural effusion due to heart failure
Source: Annual Congress 2008 - Pleural effusion
Year: 2008
Pleural fluid and plasma D-dimer levels tuberculous pleurisy: the diagnostic value and relation with clinical parameters
Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Year: 2009
The diagnostic role of pleural fluid and serum Pentraxin-3 levels in the determination of the etiology of pleural effusion
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017
Serum C-reactive protein levels predict the need for surgical intervention in patients with empyema/complicated parapneumonic pleural effusions
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019
Urinary neopterin measurement: as a noninvasive diagnostic method in pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 158s
Year: 2003
Diagnostic value of procalcitonin and C-reactive protein in the differentiation among bening and malignant pleural effusion
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Procalcitonin as a diagnostic tool in systemic bacterial sepsis
Source: Annual Congress 2009 - Severe sepsis and multiple organ failure
Year: 2009
The use of pleural fluid C-reactive protein level, as a diagnostic marker for pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept